Targeting NOX, INOS and COX‐2 in inflammatory cells: Chemoprevention using food phytochemicals

10.1038/nature01322

10.1038/35077256

10.1016/j.mrfmmm.2005.04.019

Thun MJ, 1993, Aspirin use and risk of fatal cancer, Cancer Res, 53, 1322

Sergeant S, 1997, Opsonized zymosan stimulates the redistribution of protein kinase C isoforms in human neutrophils, J Immunol, 159, 2877, 10.4049/jimmunol.159.6.2877

Nixon JB, 1999, Protein kinase C (PKC) isoforms translocate to Triton‐insoluble fractions in stimulated human neutrophils: correlation of conventional PKC with activation of NADPH oxidase, J Immunol, 163, 4574, 10.4049/jimmunol.163.8.4574

10.1006/abbi.1996.0470

10.1046/j.1523-1755.2003.00702.x

10.1161/01.HYP.0000037063.90643.0B

10.1161/01.CIR.0000124223.00113.A4

10.1016/S0952-7915(03)00109-2

10.3181/00379727-208-43844

10.1159/000227593

10.1080/01635589309514265

Ji C, 1992, Oxygen radical‐dependent epoxydation of (7S,8S)‐dihydroxy‐7,8‐dihydrobenzo[a]pyrene in mouse skin in vivo. Stimulation by phorbol esters and inhibition by antiinflammatory steroids, J Biol Chem, 267, 17842, 10.1016/S0021-9258(19)37120-0

Nakamura Y, 1998, Suppression of tumor promoter‐induced oxidative stress and inflammatory responses in mouse skin by a superoxide generation inhibitor 1′‐acetoxychavicol acetate, Cancer Res, 58, 4832

10.1093/carcin/21.10.1843

Murakami A, 2000, Inhibitory effect of citrus nobiletin on phorbol ester‐induced skin inflammation, oxidative stress, and tumor promotion in mice, Cancer Res, 60, 5059

10.1002/ijc.20175

10.1089/ars.2005.7.1621

10.1073/pnas.82.15.5194

10.1093/carcin/24.2.235

10.1093/carcin/bgh051

10.1016/S0027-5107(02)00331-7

10.1046/j.1365-2249.2002.01959.x

10.1165/ajrcmb.26.1.4477

Hao XP, 2001, Inducible nitric oxide synthase (iNOS) is expressed similarly in multiple aberrant crypt foci and colorectal tumors from the same patients, Cancer Res, 61, 419

10.1097/00054725-200305000-00006

10.1006/niox.1997.0143

10.1074/jbc.M112270200

10.1002/ijc.10808

10.1016/S0006-291X(02)02029-6

10.1016/j.niox.2005.06.009

10.1016/j.bbrc.2003.10.003

10.1006/bbrc.1995.1076

10.1016/S0006-2952(00)00489-5

10.1016/j.lfs.2006.06.048

10.1016/S0006-2952(98)00114-2

10.1016/j.intimp.2006.11.006

10.1038/sj.bjp.0702357

10.1016/S0006-2952(00)00471-8

10.1016/S0960-894X(99)00702-7

10.1124/mol.52.3.465

10.1016/S0006-2952(97)00504-2

10.1002/art.10443

10.1016/S0891-5849(02)01004-3

Suzuki M, 2004, Protective effects of green tea catechins on cerebral ischemic damage, Med Sci Monit, 10, BR166

10.1007/BF02976881

10.1074/jbc.M309114200

10.1016/S0024-3205(02)01685-5

10.1055/s-2003-42790

Marczin N, 1993, Tyrosine kinase inhibitors suppress endotoxin‐ and IL‐1 beta‐induced NO synthesis in aortic smooth muscle cells, Am J Physiol, 265, H1014

10.1093/carcin/23.5.795

10.1073/pnas.86.4.1178

10.1002/j.1552-4604.1995.tb04050.x

10.1074/jbc.M001611200

10.1128/MCB.20.12.4265-4274.2000

10.1093/emboj/cdf639

10.1074/jbc.M301481200

10.1074/jbc.274.16.10689

10.1038/sj.onc.1203219

10.1074/jbc.M108282200

10.4049/jimmunol.164.6.3018

10.1016/j.lfs.2003.09.025

10.1126/science.275.5297.218

10.4049/jimmunol.164.12.6509

10.1074/jbc.273.34.21875

10.1074/jbc.M314302200

10.1158/1535-7163.MCT-06-0216

10.1093/carcin/bgi349

10.1093/carcin/20.3.445

10.1016/S0304-3835(01)00655-3

Plummer SM, 2001, Clinical development of leukocyte cyclooxygenase 2 activity as a systemic biomarker for cancer chemopreventive agents, Cancer Epidemiol Biomarkers Prev, 10, 1295

10.1152/ajpgi.00230.2002

10.1093/carcin/bgg078

10.1254/jphs.94.325

10.1093/carcin/bgh165

10.1093/carcin/bgg107

10.1016/S0024-3205(01)01277-2

10.1093/jn/135.12.2987S

Huang MT, 1988, Inhibitory effect of curcumin, chlorogenic acid, caffeic acid, and ferulic acid on tumor promotion in mouse skin by 12‐O‐tetradecanoylphorbol‐13‐acetate, Cancer Res, 48, 5941

Tanaka T, 1994, Chemoprevention of 4‐nitroquinoline 1‐oxide‐induced oral carcinogenesis by dietary curcumin and hesperidin: comparison with the protective effect of beta‐carotene, Cancer Res, 54, 4653

10.1111/j.1349-7006.2000.tb01031.x

10.1093/carcin/19.8.1357

10.1093/carcin/22.5.821

Rao CV, 1995, Chemoprevention of colon carcinogenesis by dietary curcumin, a naturally occurring plant phenolic compound, Cancer Res, 55, 259

10.1093/carcin/21.2.331

10.1093/carcin/19.6.1039

10.1016/j.bbrc.2005.05.073

10.1007/978-0-387-46401-5_21

10.1093/carcin/23.9.1531

10.1207/S15327914nc391_14

10.1093/carcin/bgi286

Banerjee S, 2002, Suppression of 7,12‐dimethylbenz(a)anthracene‐induced mammary carcinogenesis in rats by resveratrol: role of nuclear factor‐kappaB, cyclooxygenase 2, and matrix metalloprotease 9, Cancer Res, 62, 4945

10.1016/0091-7435(92)90057-O

Yamane T, 1995, Inhibition of N‐methyl‐N′‐nitro‐N‐nitrosoguanidine‐induced carcinogenesis by (‐)‐epigallocatechin gallate in the rat glandular stomach, Cancer Res, 55, 2081

10.1158/0008-5472.CAN-05-1949

10.1016/S0304-3835(01)00767-4

Bettuzzi S, 2007, Clinical relevance of the inhibitory effect of green tea catechins (GtCs) on prostate cancer progression in combination with molecular profiling of catechin‐resistant tumors: an integrated view, Pol J Vet Sci, 10, 57

10.1093/carcin/bgi147

10.1093/carcin/15.8.1555

10.1016/0304-3835(93)90237-4

10.1016/j.canlet.2005.10.028

10.1093/carcin/19.8.1509

10.1002/(SICI)1097-0215(19990129)80:3<396::AID-IJC10>3.0.CO;2-1

10.1093/carcin/16.11.2833

Mentor‐Marcel R, 2001, Genistein in the diet reduces the incidence of poorly differentiated prostatic adenocarcinoma in transgenic mice (TRAMP), Cancer Res, 61, 6777

10.1093/carcin/20.10.1945

10.1207/s15327914nc4802_5

Takimoto CH, 2003, Phase I pharmacokinetic and pharmacodynamic analysis of unconjugated soy isoflavones administered to individuals with cancer, Cancer Epidemiol Biomarkers Prev, 12, 1213

10.1111/j.1349-7006.1996.tb00229.x

10.1111/j.1349-7006.2000.tb00926.x

10.1111/j.1349-7006.1997.tb00457.x

10.1093/carcin/19.10.1809

10.1007/978-0-387-46401-5_20

10.1002/mnfr.200500002

10.1093/jn/133.10.3262S

10.3109/00498258809041680

10.1080/01635580701267677